Ethical challenges of precision cancer medicine

Amongst common diseases, cancer is often both a leader in self-regulatory policy, or the field for contentious ethical issues such as the patenting of the BRCA1/2 genes. With the advent of genomic sequencing technologies, achieving precision cancer medicine requires prospective norms due to the larg...

Full description

Saved in:
Bibliographic Details
Main Authors: Winkler, Eva C. (Author) , Knoppers, Bartha Maria (Author)
Format: Article (Journal)
Language:English
Published: September 2022
In: Seminars in cancer biology
Year: 2022, Volume: 84, Pages: 263-270
ISSN:1096-3650
DOI:10.1016/j.semcancer.2020.09.009
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.semcancer.2020.09.009
Verlag, lizenzpflichtig, Volltext: https://www.webofscience.com/api/gateway?GWVersion=2&SrcAuth=DynamicDOIArticle&SrcApp=WOS&KeyAID=10.1016%2Fj.semcancer.2020.09.009&DestApp=DOI&SrcAppSID=EUW1ED0A98PuZ6GfPsDNoyFijutk1&SrcJTitle=SEMINARS+IN+CANCER+BIOLOGY&DestDOIRegistrantName=Elsevier
Get full text
Author Notes:Eva Caroline Winkler, Bartha Maria Knoppers

MARC

LEADER 00000caa a2200000 c 4500
001 1817894536
003 DE-627
005 20230426141100.0
007 cr uuu---uuuuu
008 220930s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.semcancer.2020.09.009  |2 doi 
035 |a (DE-627)1817894536 
035 |a (DE-599)KXP1817894536 
035 |a (OCoLC)1361695997 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Winkler, Eva C.  |d 1971-  |e VerfasserIn  |0 (DE-588)1055853065  |0 (DE-627)792734823  |0 (DE-576)411905384  |4 aut 
245 1 0 |a Ethical challenges of precision cancer medicine  |c Eva Caroline Winkler, Bartha Maria Knoppers 
264 1 |c September 2022 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.09.2022 
520 |a Amongst common diseases, cancer is often both a leader in self-regulatory policy, or the field for contentious ethical issues such as the patenting of the BRCA1/2 genes. With the advent of genomic sequencing technologies, achieving precision cancer medicine requires prospective norms due to the large and varied sources of data involved. Here, we discuss the ethical and legal aspects of the policy debate around the relevant topics in pre-cision cancer medicine: the return of incidental findings and sequencing raw data to patients, the communication of genetic results to patients' relatives, privacy and communication risks with concomitant oversight strategies, patient participation and consent models. We present the arguments and empirical data supporting specific policy solutions delineating still contested areas. What type of consent and oversight are required to acquire genomic data or to access it where desired, either by the participant/patient or third-party researchers? Most of the raw sequencing data is still uninterpretable and the variants revealed subject to reinterpretation over time. No doubt the ethical challenges of precision cancer medicine are a prototype of what's to come for other diseases. They are also paradigmatic for regulatory and ethical questions of the translational endeavors since the two worlds - basic science and patient care - are governed by different ethical and legal principles that need to be reconciled in precision cancer medicine. 
650 4 |a Data privacy 
650 4 |a genetics 
650 4 |a genomic medicine 
650 4 |a health-care 
650 4 |a incidental findings 
650 4 |a Informed consent 
650 4 |a legal 
650 4 |a personalized medicine 
650 4 |a policy statement 
650 4 |a Research ethics 
650 4 |a research participants 
650 4 |a return 
650 4 |a Return of sequence raw data 
650 4 |a Return of genetic results 
650 4 |a secondary-findings 
700 1 |a Knoppers, Bartha Maria  |e VerfasserIn  |0 (DE-588)124367097  |0 (DE-627)085815829  |0 (DE-576)294139559  |4 aut 
773 0 8 |i Enthalten in  |t Seminars in cancer biology  |d London : Academic Press, 1995  |g 84(2022), Seite 263-270  |h Online-Ressource  |w (DE-627)268128448  |w (DE-600)1471735-9  |w (DE-576)264423526  |x 1096-3650  |7 nnas  |a Ethical challenges of precision cancer medicine 
773 1 8 |g volume:84  |g year:2022  |g pages:263-270  |g extent:8  |a Ethical challenges of precision cancer medicine 
856 4 0 |u https://doi.org/10.1016/j.semcancer.2020.09.009  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext  |7 1 
856 4 0 |u https://www.webofscience.com/api/gateway?GWVersion=2&SrcAuth=DynamicDOIArticle&SrcApp=WOS&KeyAID=10.1016%2Fj.semcancer.2020.09.009&DestApp=DOI&SrcAppSID=EUW1ED0A98PuZ6GfPsDNoyFijutk1&SrcJTitle=SEMINARS+IN+CANCER+BIOLOGY&DestDOIRegistrantName=Elsevier  |x Verlag  |z lizenzpflichtig  |3 Volltext  |7 1 
951 |a AR 
992 |a 20220930 
993 |a Article 
994 |a 2022 
998 |g 1055853065  |a Winkler, Eva C.  |m 1055853065:Winkler, Eva C.  |d 910000  |d 912900  |d 50000  |e 910000PW1055853065  |e 912900PW1055853065  |e 50000PW1055853065  |k 0/910000/  |k 1/910000/912900/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1817894536  |e 4193648702 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1817894536","origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"September 2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1016/j.semcancer.2020.09.009"],"eki":["1817894536"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"language":["eng"],"part":{"extent":"8","pages":"263-270","text":"84(2022), Seite 263-270","year":"2022","volume":"84"},"title":[{"title_sort":"Seminars in cancer biology","title":"Seminars in cancer biology"}],"pubHistory":["Nachgewiesen 6.1995 -"],"note":["Gesehen am 21.02.20"],"disp":"Ethical challenges of precision cancer medicineSeminars in cancer biology","id":{"issn":["1096-3650"],"zdb":["1471735-9"],"eki":["268128448"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"London","dateIssuedDisp":"1995-","publisher":"Academic Press","dateIssuedKey":"1995"}],"recId":"268128448"}],"note":["Gesehen am 30.09.2022"],"name":{"displayForm":["Eva Caroline Winkler, Bartha Maria Knoppers"]},"person":[{"family":"Winkler","display":"Winkler, Eva C.","given":"Eva C.","role":"aut"},{"family":"Knoppers","display":"Knoppers, Bartha Maria","role":"aut","given":"Bartha Maria"}],"title":[{"title_sort":"Ethical challenges of precision cancer medicine","title":"Ethical challenges of precision cancer medicine"}],"language":["eng"]} 
SRT |a WINKLEREVAETHICALCHA2022